This oral formulation offers a more convenient delivery method compared to intravenous treatments.
Philips has pioneered this detector-based spectral CT approach that produces multiple spectral outputs from a single scan without sacrificing performance or increasing scan time.
The new approach, published in Clinical Cancer Research, may equip clinicians with an additional tool to track tumor changes over time and modify treatment strategies accordingly.